BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 28394299)

  • 21. Dysregulated Transcriptional Control in Prostate Cancer.
    Baumgart SJ; Nevedomskaya E; Haendler B
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.
    Udayappan UK; Casey PJ
    Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299
    [No Abstract]   [Full Text] [Related]  

  • 23. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JUN-CCAAT/enhancer-binding protein complexes inhibit surfactant-associated protein B promoter activity.
    Bein K; Leight H; Leikauf GD
    Am J Respir Cell Mol Biol; 2011 Aug; 45(2):436-44. PubMed ID: 21148742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of sLZIP in transcriptional regulation of c-Jun and involvement in migration and invasion of cervical cancer cells.
    Park E; Kang H; Kim J; Ko J
    Cell Physiol Biochem; 2014; 33(1):151-64. PubMed ID: 24481121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proto-oncogenic miR-744 is upregulated by transcription factor c-Jun via a promoter activation mechanism.
    Sha Z; Zhu X; Li N; Li Y; Li D
    Oncotarget; 2016 Oct; 7(40):64977-64986. PubMed ID: 27533465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
    Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
    Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer cell invasion mediated by Gα12 signaling involves expression of interleukins-6 and -8, and matrix metalloproteinase-2.
    Chia CY; Kumari U; Casey PJ
    J Mol Signal; 2014; 9():6. PubMed ID: 24976858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
    Sioletic S; Czaplinski J; Hu L; Fletcher JA; Fletcher CD; Wagner AJ; Loda M; Demetri GD; Sicinska ET; Snyder EL
    J Pathol; 2014 Oct; 234(2):190-202. PubMed ID: 24852265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MatrixCatch--a novel tool for the recognition of composite regulatory elements in promoters.
    Deyneko IV; Kel AE; Kel-Margoulis OV; Deineko EV; Wingender E; Weiss S
    BMC Bioinformatics; 2013 Aug; 14():241. PubMed ID: 23924163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-182 and microRNA-200a control G-protein subunit α-13 (GNA13) expression and cell invasion synergistically in prostate cancer cells.
    Rasheed SAK; Teo CR; Beillard EJ; Voorhoeve PM; Casey PJ
    J Biol Chem; 2013 Mar; 288(11):7986-7995. PubMed ID: 23329838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G12 signaling through c-Jun NH2-terminal kinase promotes breast cancer cell invasion.
    Juneja J; Cushman I; Casey PJ
    PLoS One; 2011; 6(11):e26085. PubMed ID: 22087220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of G12 proteins in oncogenesis and metastasis.
    Juneja J; Casey PJ
    Br J Pharmacol; 2009 Sep; 158(1):32-40. PubMed ID: 19422395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis.
    Kelly P; Casey PJ; Meigs TE
    Biochemistry; 2007 Jun; 46(23):6677-87. PubMed ID: 17503779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.
    Kelly P; Stemmle LN; Madden JF; Fields TA; Daaka Y; Casey PJ
    J Biol Chem; 2006 Sep; 281(36):26483-90. PubMed ID: 16787920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer.
    Vleugel MM; Greijer AE; Bos R; van der Wall E; van Diest PJ
    Hum Pathol; 2006 Jun; 37(6):668-74. PubMed ID: 16733206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis.
    Kelly P; Moeller BJ; Juneja J; Booden MA; Der CJ; Daaka Y; Dewhirst MW; Fields TA; Casey PJ
    Proc Natl Acad Sci U S A; 2006 May; 103(21):8173-8. PubMed ID: 16705036
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.